Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations

References

• Busse WW, Lemanske RF, Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet. 2010;376(9743):826–834. doi:10.1016/S0140-6736(10)61380-3
   PubMed Web of Science ®Google Scholar
• Resiliac J, Grayson MH. Epidemiology of infections and development of asthma. Immunol Allergy Clin North Am. 2019;39(3):297–307. doi:10.1016/j.iac.2019.03.001
   PubMed Web of Science ®Google Scholar
• Iikura M, Hojo M, Koketsu R, et al. The importance of bacterial and viral infections associated with adult asthma exacerbations in clinical practice. PLoS One. 2015;10(4):e0123584. doi:10.1371/journal.pone.0123584
   PubMed Web of Science ®Google Scholar
• Hahn DL. Infectious asthma: a reemerging clinical entity? J Fam Pract. 1995;41(2):153–157.
   PubMed Web of Science ®Google Scholar
• Helby J, Nordestgaard BG, Benfield T, Bojesen SE. Asthma, other atopic conditions and risk of infections in 105 519 general population never and ever smokers. J Intern Med. 2017;282(3):254–267. doi:10.1111/joim.12635
   PubMed Web of Science ®Google Scholar
• Rossi GA, Colin AA. Infantile respiratory syncytial virus and human rhinovirus infections: respective role in inception and persistence of wheezing. Eur Respir J. 2015;45(3):774–789. doi:10.1183/09031936.00062714
   PubMed Web of Science ®Google Scholar
• Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008;178(7):667–672. doi:10.1164/rccm.200802-309OC
   PubMed Web of Science ®Google Scholar
• Tregoning JS, Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev. 2010;23(1):74–98. doi:10.1128/CMR.00032-09
   PubMed Web of Science ®Google Scholar
• Mohapatra SS, Boyapalle S. Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma. Clin Microbiol Rev. 2008;21(3):495–504. doi:10.1128/CMR.00054-07
   PubMed Web of Science ®Google Scholar
• Jartti T, Gern JE. Role of viral infections in the development and exacerbation of asthma in children. J Allergy Clin Immunol. 2017;140(4):895–906. doi:10.1016/j.jaci.2017.08.003
   PubMed Web of Science ®Google Scholar
• Wark PA, Gibson PG. Asthma exacerbations 3: pathogenesis. Thorax. 2006;61(10):909–915. doi:10.1136/thx.2005.045187
   PubMed Web of Science ®Google Scholar
• Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000;161(5):1501–1507. doi:10.1164/ajrccm.161.5.9906076
   PubMed Web of Science ®Google Scholar
• Pullan CR, Hey EN. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J. 1982;284(6330):1665–1669. doi:10.1136/bmj.284.6330.1665
   PubMedGoogle Scholar
• Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354(9178):541–545. doi:10.1016/S0140-6736(98)10321-5
   PubMed Web of Science ®Google Scholar
• Parrott RH, Kim HW, Arrobio JO, et al. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol. 1973;98(4):289–300. doi:10.1093/oxfordjournals.aje.a121558
   PubMed Web of Science ®Google Scholar
• Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med. 2005;171(2):137–141. doi:10.1164/rccm.200406-730OC
   PubMed Web of Science ®Google Scholar
• Schauer U, Hoffjan S, Bittscheidt J, et al. RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life. Eur Respir J. 2002;20(5):1277–1283. doi:10.1183/09031936.02.00019902
   PubMed Web of Science ®Google Scholar
• Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749–1759. doi:10.1056/NEJMoa043951
   PubMed Web of Science ®Google Scholar
• Alwan WH, Openshaw PJ. Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins. Vaccine. 1993;11(4):431–437. doi:10.1016/0264-410X(93)90284-5
   PubMed Web of Science ®Google Scholar
• Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2003;168(6):633–639. doi:10.1164/rccm.200210-1148OC
   PubMed Web of Science ®Google Scholar
• Domachowske JB, Rosenberg HF. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev. 1999;12(2):298–309. doi:10.1128/CMR.12.2.298
   PubMed Web of Science ®Google Scholar
• Alwan WH, Kozlowska WJ, Openshaw PJ. Distinct types of lung disease caused by functional subsets of antiviral T cells. J Exp Med. 1994;179(1):81–89. doi:10.1084/jem.179.1.81
   PubMed Web of Science ®Google Scholar
• Russell CD, Unger SA, Walton M, Schwarze J. The human immune response to respiratory syncytial virus infection. Clin Microbiol Rev. 2017;30(2):481–502. doi:10.1128/CMR.00090-16
   PubMed Web of Science ®Google Scholar
• Manti S, Piedimonte G. An overview on the RSV-mediated mechanisms in the onset of non-allergic asthma. Front Pediatr. 2022;10:998296.
   PubMed Web of Science ®Google Scholar
• Culley FJ, Pollott J, Openshaw PJ. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med. 2002;196(10):1381–1386. doi:10.1084/jem.20020943
   PubMed Web of Science ®Google Scholar
• Varga SM, Wang X, Welsh RM, Braciale TJ. Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells. Immunity. 2001;15(4):637–646. doi:10.1016/S1074-7613(01)00209-6
   PubMed Web of Science ®Google Scholar
• Openshaw P, Murphy EE, Hosken NA, et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med. 1995;182(5):1357–1367. doi:10.1084/jem.182.5.1357
   PubMed Web of Science ®Google Scholar
• Sigurs N, Aljassim F, Kjellman B, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax. 2010;65(12):1045–1052. doi:10.1136/thx.2009.121582
   PubMed Web of Science ®Google Scholar
• Piedimonte G. RSV infections: state of the art. Cleve Clin J Med. 2015;82(11 Suppl 1):S13–S18. doi:10.3949/ccjm.82.s1.03
   PubMedGoogle Scholar
• Papi A, Ison MG, Langley JM, et al. Respiratory syncytial virus prefusion F protein vaccine in older adults. N Engl J Med. 2023;388(7):595–608. doi:10.1056/NEJMoa2209604
   PubMed Web of Science ®Google Scholar
• Walsh EE, Perez Marc G, Zareba AM, et al. Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults. N Engl J Med. 2023;388(16):1465–1477. doi:10.1056/NEJMoa2213836
   PubMed Web of Science ®Google Scholar
• Kampmann B, Madhi SA, Munjal I, et al. Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N Engl J Med. 2023;388(16):1451–1464. doi:10.1056/NEJMoa2216480
   PubMed Web of Science ®Google Scholar
• Kistler A, Avila PC, Rouskin S, et al. Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis. 2007;196(6):817–825. doi:10.1086/520816
   PubMed Web of Science ®Google Scholar
• Moss RB. Enterovirus 68 infection--association with asthma. J Allergy Clin Immunol Pract. 2016;4(2):226–228. doi:10.1016/j.jaip.2015.12.013
   PubMed Web of Science ®Google Scholar
• Foster CB, Coelho R, Brown PM, et al. A comparison of hospitalized children with enterovirus D68 to those with rhinovirus. Pediatr Pulmonol. 2017;52(6):827–832. doi:10.1002/ppul.23661
   PubMed Web of Science ®Google Scholar
• Yeh JJ, Lin CL, Hsu WH. Effect of enterovirus infections on asthma in young children: a national cohort study. Eur J Clin Invest. 2017;47(12):e12844. doi:10.1111/eci.12844
   Web of Science ®Google Scholar
• DeMore JP, Weisshaar EH, Vrtis RF, et al. Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16. J Allergy Clin Immunol. 2009;124(2):245–252, 252 e241–243. doi:10.1016/j.jaci.2009.05.030
   Web of Science ®Google Scholar
• Mosser AG, Vrtis R, Burchell L, et al. Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am J Respir Crit Care Med. 2005;171(6):645–651. doi:10.1164/rccm.200407-970OC
   PubMed Web of Science ®Google Scholar
• Jacobs SE, Lamson DM, St George K, Walsh TJ. Human rhinoviruses. Clin Microbiol Rev. 2013;26(1):135–162. doi:10.1128/CMR.00077-12
   PubMed Web of Science ®Google Scholar
• Greve JM, Davis G, Meyer AM, et al. The major human rhinovirus receptor is ICAM-1. Cell. 1989;56(5):839–847. doi:10.1016/0092-8674(89)90688-0
   PubMed Web of Science ®Google Scholar
• Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005;201(6):937–947. doi:10.1084/jem.20041901
   PubMed Web of Science ®Google Scholar
• Papadopoulos NG, Bates PJ, Bardin PG, et al. Rhinoviruses infect the lower airways. J Infect Dis. 2000;181(6):1875–1884. doi:10.1086/315513
   PubMed Web of Science ®Google Scholar
• Gern JE, Galagan DM, Jarjour NN, Dick EC, Busse WW. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med. 1997;155(3):1159–1161. doi:10.1164/ajrccm.155.3.9117003
   PubMed Web of Science ®Google Scholar
• Terajima M, Yamaya M, Sekizawa K, et al. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1beta. Am J Physiol. 1997;273(4):L749–L759. doi:10.1152/ajplung.1997.273.4.L749
   PubMedGoogle Scholar
• Mosser AG, Brockman-Schneider R, Amineva S, et al. Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. J Infect Dis. 2002;185(6):734–743. doi:10.1086/339339
   PubMed Web of Science ®Google Scholar
• Spurrell JC, Wiehler S, Zaheer RS, Sanders SP, Proud D. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol. 2005;289(1):L85–L95. doi:10.1152/ajplung.00397.2004
   PubMed Web of Science ®Google Scholar
• Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med. 1992;176(2):587–592. doi:10.1084/jem.176.2.587
   PubMed Web of Science ®Google Scholar
• Sedgwick JB, Quan SF, Calhoun WJ, Busse WW. Effect of interleukin-5 and granulocyte-macrophage colony stimulating factor on in vitro eosinophil function: comparison with airway eosinophils. J Allergy Clin Immunol. 1995;96(3):375–385. doi:10.1016/S0091-6749(95)70057-9
   PubMed Web of Science ®Google Scholar
• Lopez AF, Williamson DJ, Gamble JR, et al. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest. 1986;78(5):1220–1228. doi:10.1172/JCI112705
   PubMed Web of Science ®Google Scholar
• Nagata M, Sedgwick JB, Bates ME, Kita H, Busse WW. Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation. J Immunol. 1995;155(4):2194–2202. doi:10.4049/jimmunol.155.4.2194
   PubMed Web of Science ®Google Scholar
• Kostakou E, Kaniaris E, Filiou E, et al. Acute severe asthma in adolescent and adult patients: current perspectives on assessment and management. J Clin Med. 2019;8(9):1283. doi:10.3390/jcm8091283
   PubMed Web of Science ®Google Scholar
• Corne JM, Marshall C, Smith S, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet. 2002;359(9309):831–834. doi:10.1016/S0140-6736(02)07953-9
   PubMed Web of Science ®Google Scholar
• Branche AR, Falsey AR. Parainfluenza virus infection. Semin Respir Crit Care Med. 2016;37(4):538–554. doi:10.1055/s-0036-1584798
   PubMed Web of Science ®Google Scholar
• Henrickson KJ. Parainfluenza viruses. Clin Microbiol Rev. 2003;16(2):242–264. doi:10.1128/CMR.16.2.242-264.2003
   PubMed Web of Science ®Google Scholar
• Matsuse H, Kondo Y, Saeki S, et al. Naturally occurring parainfluenza virus 3 infection in adults induces mild exacerbation of asthma associated with increased sputum concentrations of cysteinyl leukotrienes. Int Arch Allergy Immunol. 2005;138(3):267–272. doi:10.1159/000088728
   PubMed Web of Science ®Google Scholar
• Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086–5096. doi:10.1016/j.vaccine.2007.03.046
   PubMed Web of Science ®Google Scholar
• Coverstone AM, Wang L, Sumino K. Beyond respiratory syncytial virus and rhinovirus in the pathogenesis and exacerbation of asthma: the role of metapneumovirus, bocavirus and influenza virus. Immunol Allergy Clin North Am. 2019;39(3):391–401. doi:10.1016/j.iac.2019.03.007
   PubMed Web of Science ®Google Scholar
• Teichtahl H, Buckmaster N, Pertnikovs E. The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest. 1997;112(3):591–596. doi:10.1378/chest.112.3.591
   PubMed Web of Science ®Google Scholar
• Heymann PW, Carper HT, Murphy DD, et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol. 2004;114(2):239–247. doi:10.1016/j.jaci.2004.04.006
   PubMed Web of Science ®Google Scholar
• Zheng XY, Xu YJ, Guan WJ, Lin LF. Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review. Arch Virol. 2018;163(4):845–853. doi:10.1007/s00705-017-3700-y
   PubMed Web of Science ®Google Scholar
• Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361(20):1935–1944. doi:10.1056/NEJMoa0906695
   PubMed Web of Science ®Google Scholar
• Dawood FS, Kamimoto L, D’Mello TA, et al. Children with asthma hospitalized with seasonal or pandemic influenza, 2003–-2009. Pediatrics. 2011;128(1):e27–e32. doi:10.1542/peds.2010-3343
   PubMed Web of Science ®Google Scholar
• Contoli M, Message SD, Laza-Stanca V, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med. 2006;12(9):1023–1026. doi:10.1038/nm1462
   PubMed Web of Science ®Google Scholar
• Kloepfer KM, Olenec JP, Lee WM, et al. Increased H1N1 infection rate in children with asthma. Am J Respir Crit Care Med. 2012;185(12):1275–1279. doi:10.1164/rccm.201109-1635OC
   PubMed Web of Science ®Google Scholar
• Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2022–23 influenza season. MMWR Recomm Rep. 2022;71(1):1–28. doi:10.15585/mmwr.rr7101a1
   PubMedGoogle Scholar
• Williams JV, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004;350(5):443–450. doi:10.1056/NEJMoa025472
   PubMed Web of Science ®Google Scholar
• Agapov E, Sumino KC, Gaudreault-Keener M, Storch GA, Holtzman MJ. Genetic variability of human metapneumovirus infection: evidence of a shift in viral genotype without a change in illness. J Infect Dis. 2006;193(3):396–403. doi:10.1086/499310
   PubMed Web of Science ®Google Scholar
• Bakakos A, Krompa A. Asthma in the era of SARS CoV-2 virus. J Asthma. 2022;59(8):1501–1508. doi:10.1080/02770903.2021.1941093
   PubMed Web of Science ®Google Scholar
• Yao Y, Wang H, Liu Z. Expression of ACE2 in airways: implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases. Clin Exp Allergy. 2020;50(12):1313–1324. doi:10.1111/cea.13746
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280 e278. doi:10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648
   PubMed Web of Science ®Google Scholar
• Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. doi:10.1016/j.jaci.2020.04.006
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–1741. doi:10.1111/all.14238
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Cao YY, Dong X, et al. Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2. Allergy. 2020;75(7):1809–1812. doi:10.1111/all.14316
   PubMed Web of Science ®Google Scholar
• Adir Y, Saliba W, Beurnier A, Humbert M. Asthma and COVID-19: an update. Eur Respir Rev. 2021;30(162):210152. doi:10.1183/16000617.0152-2021
   PubMed Web of Science ®Google Scholar
• Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436. doi:10.1038/s41586-020-2521-4
   PubMed Web of Science ®Google Scholar
• Liu S, Cao Y, Du T, Zhi Y. Prevalence of comorbid asthma and related outcomes in COVID-19: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2021;9(2):693–701. doi:10.1016/j.jaip.2020.11.054
   PubMed Web of Science ®Google Scholar
• Choi YJ, Park JY, Lee HS, et al. Effect of asthma and asthma medication on the prognosis of patients with COVID-19. Eur Respir J. 2021;57(3):2002226. doi:10.1183/13993003.02226-2020
   PubMed Web of Science ®Google Scholar
• Peters MC, Sajuthi S, Deford P, et al. COVID-19-related genes in sputum cells in asthma. Relationship to demographic features and corticosteroids. Am J Respir Crit Care Med. 2020;202(1):83–90. doi:10.1164/rccm.202003-0821OC
   PubMed Web of Science ®Google Scholar
• Chen CH, Chen CY, Lai CC, et al. The association between inhaled corticosteroid and the risks of SARS-COV-2 infection: a systematic review and meta-analysis. J Infect Public Health. 2023;16(5):823–830. doi:10.1016/j.jiph.2023.03.019
   PubMed Web of Science ®Google Scholar
• Song JY, Yoon JG, Seo YB, et al. Ciclesonide inhaler treatment for mild-to-moderate COVID-19: a randomized, open-label, phase 2 trial. J Clin Med. 2021;10(16):3545. doi:10.3390/jcm10163545
   PubMed Web of Science ®Google Scholar
• Ramakrishnan S, Nicolau DV Jr, Langford B, et al. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir Med. 2021;9(7):763–772. doi:10.1016/S2213-2600(21)00160-0
   PubMed Web of Science ®Google Scholar
• Yu LM, Bafadhel M, Dorward J, et al. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021;398(10303):843–855. doi:10.1016/S0140-6736(21)01744-X
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 2020;55(5):2001009. doi:10.1183/13993003.01009-2020
   PubMed Web of Science ®Google Scholar
• Farne H, Singanayagam A. Why asthma might surprisingly protect against poor outcomes in COVID-19. Eur Respir J. 2020;56(6):2003045. doi:10.1183/13993003.03045-2020
   PubMed Web of Science ®Google Scholar
• Ehre C, Worthington EN, Liesman RM, et al. Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs. Proc Natl Acad Sci U S A. 2012;109(41):16528–16533. doi:10.1073/pnas.1206552109
   PubMed Web of Science ®Google Scholar
• Boncristiani HF, Criado MF, Arruda E. Respiratory viruses. Ency Microbiol. 2009;500–5189. doi:10.1016/B978-012373944-5.00314-X
   Google Scholar
• Message SD, Johnston SL. The immunology of virus infection in asthma. Eur Respir J. 2001;18(6):1013–1025. doi:10.1183/09031936.01.00228701
   PubMed Web of Science ®Google Scholar
• van Rijt LS, van Kessel CH, Boogaard I, Lambrecht BN. Respiratory viral infections and asthma pathogenesis: a critical role for dendritic cells? J Clin Virol. 2005;34(3):161–169. doi:10.1016/j.jcv.2005.07.002
   PubMed Web of Science ®Google Scholar
• Oliver BG, Robinson P, Peters M, Black J. Viral infections and asthma: an inflammatory interface? Eur Respir J. 2014;44(6):1666–1681. doi:10.1183/09031936.00047714
   PubMed Web of Science ®Google Scholar
• Hansbro NG, Horvat JC, Wark PA, Hansbro PM. Understanding the mechanisms of viral induced asthma: new therapeutic directions. Pharmacol Ther. 2008;117(3):313–353.
   PubMed Web of Science ®Google Scholar
• Illi S, von Mutius E, Lau S, et al. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. BMJ. 2001;322(7283):390–395. doi:10.1136/bmj.322.7283.390
   PubMed Web of Science ®Google Scholar
• Dakhama A, Lee YM, Gelfand EW. Virus-induced airway dysfunction: pathogenesis and biomechanisms. Pediatr Infect Dis J. 2005;24(11 Suppl):S159–S169, discussion S166–S157. doi:10.1097/01.inf.0000188155.46381.15
   Google Scholar
• Folkerts G, Busse WW, Nijkamp FP, Sorkness R, Gern JE. Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1708–1720. doi:10.1164/ajrccm.157.6.9707163
   PubMed Web of Science ®Google Scholar
• Lommatzsch M, Korn S, Buhl R, Virchow JC. Against all odds: anti-IgE for intrinsic asthma? Thorax. 2014;69(1):94–96. doi:10.1136/thoraxjnl-2013-203738
   PubMed Web of Science ®Google Scholar
• Ackland J, Watson A, Wilkinson TMA, Staples KJ. Interrupting the conversation: implications for crosstalk between viral and bacterial infections in the asthmatic airway. Front Allergy. 2021;2:738987. doi:10.3389/falgy.2021.738987
   PubMedGoogle Scholar
• Talbot TR, Hartert TV, Mitchel E, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005;352(20):2082–2090. doi:10.1056/NEJMoa044113
   PubMed Web of Science ®Google Scholar
• Levy ML, Bacharier LB, Bateman E, et al. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update. NPJ Prim Care Respir Med. 2023;33(1):7. doi:10.1038/s41533-023-00330-1
   PubMed Web of Science ®Google Scholar
• Fergeson JE, Patel SS, Lockey RF. Acute asthma, prognosis, and treatment. J Allergy Clin Immunol. 2017;139(2):438–447. doi:10.1016/j.jaci.2016.06.054
   PubMed Web of Science ®Google Scholar
• Rakes GP, Arruda E, Ingram JM, et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care: igE and eosinophil analyses. Am J Respir Crit Care Med. 1999;159(3):785–790. doi:10.1164/ajrccm.159.3.9801052
   PubMed Web of Science ®Google Scholar
• Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ. 1995;310(6989):1225–1229. doi:10.1136/bmj.310.6989.1225
   PubMed Web of Science ®Google Scholar
• Murray CS, Poletti G, Kebadze T, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax. 2006;61(5):376–382. doi:10.1136/thx.2005.042523
   PubMed Web of Science ®Google Scholar
• Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ. 2002;324(7340):763. doi:10.1136/bmj.324.7340.763
   PubMed Web of Science ®Google Scholar
• Georas SN, Rezaee F. Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. J Allergy Clin Immunol. 2014;134(3):509–520. doi:10.1016/j.jaci.2014.05.049
   PubMed Web of Science ®Google Scholar
• Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol. 2010;125(6):1178–1187; quiz 1188–1179. doi:10.1016/j.jaci.2010.04.021
   Web of Science ®Google Scholar
• Johnson SM, McNally BA, Ioannidis I, et al. Respiratory syncytial virus uses CX3CR1 as a receptor on primary human airway epithelial cultures. PLoS Pathog. 2015;11(12):e1005318. doi:10.1371/journal.ppat.1005318
   PubMed Web of Science ®Google Scholar
• Basnet S, Palmenberg AC, Gern JE. Rhinoviruses and their receptors. Chest. 2019;155(5):1018–1025. doi:10.1016/j.chest.2018.12.012
   PubMed Web of Science ®Google Scholar
• Bochkov YA, Watters K, Ashraf S, et al. Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc Natl Acad Sci U S A. 2015;112(17):5485–5490. doi:10.1073/pnas.1421178112
   PubMed Web of Science ®Google Scholar
• Moore WC, Hastie AT, Li X, et al. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J Allergy Clin Immunol. 2014;133(6):1557–1563 e1555. doi:10.1016/j.jaci.2013.10.011
   PubMed Web of Science ®Google Scholar
• Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax. 2002;57(7):643–648. doi:10.1136/thorax.57.7.643
   PubMed Web of Science ®Google Scholar
• Rodriguez-Roisin R. Acute severe asthma: pathophysiology and pathobiology of gas exchange abnormalities. Eur Respir J. 1997;10(6):1359–1371. doi:10.1183/09031936.97.10061359
   PubMed Web of Science ®Google Scholar
• Pepe PE, Marini JJ. Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction: the auto-PEEP effect. Am Rev Respir Dis. 1982;126(1):166–170. doi:10.1164/arrd.1982.126.1.166
   PubMed Web of Science ®Google Scholar
• Barnes PJ. How corticosteroids control inflammation: Quintiles prize lecture 2005. Br J Pharmacol. 2006;148(3):245–254. doi:10.1038/sj.bjp.0706736
   PubMed Web of Science ®Google Scholar
• Edwards MR, Johnson MW, Johnston SL. Combination therapy: synergistic suppression of virus-induced chemokines in airway epithelial cells. Am J Respir Cell Mol Biol. 2006;34(5):616–624. doi:10.1165/rcmb.2005-0385OC
   PubMed Web of Science ®Google Scholar
• Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev. 1996;2001(1):CD002178.
   Google Scholar
• Krishnan JA, Davis SQ, Naureckas ET, Gibson P, Rowe BH. An umbrella review: corticosteroid therapy for adults with acute asthma. Am J Med. 2009;122(11):977–991. doi:10.1016/j.amjmed.2009.02.013
   PubMed Web of Science ®Google Scholar
• Price D, Castro M, Bourdin A, Fucile S, Altman P. Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety. Eur Respir Rev. 2020;29(155):190151. doi:10.1183/16000617.0151-2019
   PubMed Web of Science ®Google Scholar
• Griffiths B, Ducharme FM. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev. 2013;8:CD000060. doi:10.1002/14651858.CD000060.pub2
   PubMed Web of Science ®Google Scholar
• Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax. 2005;60(9):740–746. doi:10.1136/thx.2005.047803
   PubMed Web of Science ®Google Scholar
• Cosio BG, Mann B, Ito K, et al. Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Am J Respir Crit Care Med. 2004;170(2):141–147. doi:10.1164/rccm.200305-659OC
   PubMed Web of Science ®Google Scholar
• Celis P, Rada G. High-dose inhaled corticosteroids or addition of theophylline in patients with poorly controlled asthma? Medwave. 2015;15(Suppl 2):e6224. doi:10.5867/medwave.2015.6224
   PubMedGoogle Scholar
• BinMahfouz H, Borthakur B, Yan D, George T, Giembycz MA, Newton R. Superiority of combined phosphodiesterase PDE3/PDE4 inhibition over PDE4 inhibition alone on glucocorticoid- and long-acting beta2-adrenoceptor agonist-induced gene expression in human airway epithelial cells. Mol Pharmacol. 2015;87(1):64–76. doi:10.1124/mol.114.093393
   PubMed Web of Science ®Google Scholar
• Lipworth BJ. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease. Lancet. 2005;365(9454):167–175. doi:10.1016/S0140-6736(05)17708-3
   PubMed Web of Science ®Google Scholar
• Bardin P, Kanniess F, Gauvreau G, Bredenbroker D, Rabe KF. Roflumilast for asthma: efficacy findings in mechanism of action studies. Pulm Pharmacol Ther. 2015;35(Suppl):S4–S10. doi:10.1016/j.pupt.2015.08.006
   PubMed Web of Science ®Google Scholar
• Laidlaw TM, Boyce JA. Cysteinyl leukotriene receptors, old and new; implications for asthma. Clin Exp Allergy. 2012;42(9):1313–1320. doi:10.1111/j.1365-2222.2012.03982.x
   PubMed Web of Science ®Google Scholar
• Camargo CA Jr, Gurner DM, Smithline HA, et al. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol. 2010;125(2):374–380. doi:10.1016/j.jaci.2009.11.015
   PubMed Web of Science ®Google Scholar
• Seymour ML, Gilby N, Bardin PG, et al. Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects. J Infect Dis. 2002;185(4):540–544. doi:10.1086/338570
   PubMed Web of Science ®Google Scholar
• Message SD, Laza-Stanca V, Mallia P, et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A. 2008;105(36):13562–13567. doi:10.1073/pnas.0804181105
   PubMed Web of Science ®Google Scholar
• Tay H, Wark PA, Bartlett NW. Advances in the treatment of virus-induced asthma. Expert Rev Respir Med. 2016;10(6):629–641. doi:10.1080/17476348.2016.1180249
   PubMed Web of Science ®Google Scholar
• Barlow JL, Bellosi A, Hardman CS, et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol. 2012;129(1):191–198 e191–194. doi:10.1016/j.jaci.2011.09.041
   Web of Science ®Google Scholar
• Bartemes KR, Kephart GM, Fox SJ, Kita H. Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol. 2014;134(3):671–678 e674. doi:10.1016/j.jaci.2014.06.024
   PubMed Web of Science ®Google Scholar
• Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med. 2000;161(1):64–72. doi:10.1164/ajrccm.161.1.9809100
   PubMed Web of Science ®Google Scholar
• Contoli M, Ito K, Padovani A, et al. Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells. Allergy. 2015;70(8):910–920. doi:10.1111/all.12627
   PubMed Web of Science ®Google Scholar
• Steinke JW. Anti-interleukin-4 therapy. Immunol Allergy Clin North Am. 2004;24(4):599–614, vi. doi:10.1016/j.iac.2004.06.008
   PubMed Web of Science ®Google Scholar
• Hart TK, Blackburn MN, Brigham-Burke M, et al. Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma. Clin Exp Immunol. 2002;130(1):93–100. doi:10.1046/j.1365-2249.2002.01973.x
   PubMed Web of Science ®Google Scholar
• Hanania NA, Noonan M, Corren J, et al. Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies. Thorax. 2015;70(8):748–756. doi:10.1136/thoraxjnl-2014-206719
   PubMed Web of Science ®Google Scholar
• Piper E, Brightling C, Niven R, et al. A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma. Eur Respir J. 2013;41(2):330–338. doi:10.1183/09031936.00223411
   PubMed Web of Science ®Google Scholar
• Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med. 2013;368(26):2455–2466. doi:10.1056/NEJMoa1304048
   PubMed Web of Science ®Google Scholar
• Bakakos A, Schleich F, Bakakos P. Biological therapy of severe asthma and nasal polyps. J Pers Med. 2022;12(6):976. doi:10.3390/jpm12060976
   PubMed Web of Science ®Google Scholar
• Ortega HG, Liu MC, Pavord ID, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014;371(13):1198–1207. doi:10.1056/NEJMoa1403290
   PubMed Web of Science ®Google Scholar
• Efthimiou J, Poll C, Barnes PJ. Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation. Eur Respir J. 2019;54(1):1802390. doi:10.1183/13993003.02390-2018
   PubMed Web of Science ®Google Scholar
• MacGlashan DW Jr, Bochner BS, Adelman DC, et al. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol. 1997;158(3):1438–1445. doi:10.4049/jimmunol.158.3.1438
   PubMed Web of Science ®Google Scholar
• Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH. Anti-IgE for chronic asthma in adults and children. Cochrane Database Syst Rev. 2006;2:CD003559. doi:10.1002/14651858.CD003559.pub3
   PubMed Web of Science ®Google Scholar
• Teach SJ, Gill MA, Togias A, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol. 2015;136(6):1476–1485. doi:10.1016/j.jaci.2015.09.008
   PubMed Web of Science ®Google Scholar
• Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med. 2011;364(11):1005–1015. doi:10.1056/NEJMoa1009705
   PubMed Web of Science ®Google Scholar
• Chanez P, Contin-Bordes C, Garcia G, et al. Omalizumab-induced decrease of FcxiRI expression in patients with severe allergic asthma. Respir Med. 2010;104(11):1608–1617. doi:10.1016/j.rmed.2010.07.011
   PubMed Web of Science ®Google Scholar
• Mahmutovic-Persson I, Akbarshahi H, Bartlett NW, et al. Inhaled dsRNA and rhinovirus evoke neutrophilic exacerbation and lung expression of thymic stromal lymphopoietin in allergic mice with established experimental asthma. Allergy. 2014;69(3):348–358. doi:10.1111/all.12329
   PubMed Web of Science ®Google Scholar
• Ballantyne SJ, Barlow JL, Jolin HE, et al. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol. 2007;120(6):1324–1331. doi:10.1016/j.jaci.2007.07.051
   PubMed Web of Science ®Google Scholar
• Beale J, Jayaraman A, Jackson DJ, et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med. 2014;6(256):256ra134. doi:10.1126/scitranslmed.3009124
   PubMed Web of Science ®Google Scholar
• Jackson DJ, Makrinioti H, Rana BM, et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med. 2014;190(12):1373–1382. doi:10.1164/rccm.201406-1039OC
   PubMed Web of Science ®Google Scholar
• Wechsler ME, Ruddy MK, Pavord ID, et al. Efficacy and safety of Itepekimab in patients with moderate-to-severe asthma. N Engl J Med. 2021;385(18):1656–1668. doi:10.1056/NEJMoa2024257
   PubMed Web of Science ®Google Scholar
• Menzies-Gow A, Corren J, Bourdin A, et al. Tezepelumab in adults and adolescents with severe, uncontrolled asthma. N Engl J Med. 2021;384(19):1800–1809. doi:10.1056/NEJMoa2034975
   PubMed Web of Science ®Google Scholar
• Corren J, Parnes JR, Wang L, et al. Tezepelumab in adults with uncontrolled asthma. N Engl J Med. 2017;377(10):936–946. doi:10.1056/NEJMoa1704064
   PubMed Web of Science ®Google Scholar
• Calderon AA, Dimond C, Choy DF, et al. Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD. Eur Respir Rev. 2023;32(167):220144. doi:10.1183/16000617.0144-2022
   PubMed Web of Science ®Google Scholar
• Hatchwell L, Collison A, Girkin J, et al. Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia. Thorax. 2015;70(9):854–861. doi:10.1136/thoraxjnl-2014-205465
   PubMed Web of Science ®Google Scholar
• Greene CM, McElvaney NG. Toll-like receptor expression and function in airway epithelial cells. Arch Immunol Ther Exp. 2005;53(5):418–427.
   PubMed Web of Science ®Google Scholar
• Kline JN, Waldschmidt TJ, Businga TR, et al. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol. 1998;160(6):2555–2559. doi:10.4049/jimmunol.160.6.2555
   PubMed Web of Science ®Google Scholar
• Borden EC, Sen GC, Uze G, et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov. 2007;6(12):975–990. doi:10.1038/nrd2422
   PubMed Web of Science ®Google Scholar
• Schoggins JW. Interferon-stimulated genes: roles in viral pathogenesis. Curr Opin Virol. 2014;6:40–46. doi:10.1016/j.coviro.2014.03.006
   PubMed Web of Science ®Google Scholar
• Traub S, Nikonova A, Carruthers A, et al. An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation. PLoS Pathog. 2013;9(8):e1003520. doi:10.1371/journal.ppat.1003520
   PubMed Web of Science ®Google Scholar
• McGregor MC, Krings JG, Nair P, Castro M. Role of biologics in asthma. Am J Respir Crit Care Med. 2019;199(4):433–445. doi:10.1164/rccm.201810-1944CI
   PubMed Web of Science ®Google Scholar